Disc Medicine, Inc. (NASDAQ:IRON) is one of the 13 Small Cap Stocks Analysts Are Bullish On. In a report released on June 16, ...

Investing.com -- Syndax Pharmaceuticals Inc (NASDAQ: SNDX) stock gained 2.5% after the FDA granted Priority Review for its supplemental New Drug Application (sNDA) for Revuforj, potentially expanding ...

PDUFA action date set for October 25, 2025 – – sNDA being reviewed under FDA’s RTOR program – – Revumenib has the potential to become the first and only menin inhibitor approved in both R/R mNPM1 AML ...

With the summer humidity plopped right over Central New York, catching a flick in a nice air-conditioned theater may not sound too bad. This week, Bridge Street’s Brian ...